Related Articles
ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis
Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells
P4HA2 promotes cell proliferation and migration in glioblastoma